Global Artificial Blood Substitutes Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 6.67 Million |
 Market Size (Forecast Year) |
USD 29.24 Million |
 CAGR |
% |
| Major Markets Players |
|
Global Artificial Blood Substitutes Market, By Product Type (Perflurocarbon (PFCs), Hemoglobin-Based Oxygen Carries (HBOCs)), Source (Human Blood, Animal Blood, Microorganism Based Recombinant HB, Synthetic Polymers, Stem Cells), Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), End User (Hospital and Clinics, Blood Banks, Others) – Industry Trends and Forecast to 2030.
Artificial Blood Substitutes Market Analysis and Size
Artificial blood is used for restoring oxygen delivery after loss of blood from trauma, especially in emergency and battlefield situations, preventing the need for blood transfusions during surgery. It is a substitute blood product that can perform blood's most important function, which is the transport of oxygen and carbon dioxide. Artificial blood could be a life-saving measure, particularly in times of severe blood loss during large disasters; however, the products currently in development are incapable of performing secondary functions of blood, such as fighting infections.
Data Bridge Market Research analyses that the global artificial blood substitutes market which was USD 6.67 million in 2022, is expected to reach USD 29.24 million by 2030, and is likely to undergo a CAGR of 20.4% during the forecast period. “Hospital and Clinics” dominates the end user segment of the global artificial blood substitutes market owing to the growing demand for better diagnosis and treatment methods. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2016-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Perflurocarbon (PFCs), Hemoglobin-Based Oxygen Carries (HBOCs)), Source (Human Blood, Animal Blood, Microorganism Based Recombinant HB, Synthetic Polymers, Stem Cells), Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), End User (Hospital and Clinics, Blood Banks, Others ) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America |
|
Market Players Covered |
Aurum Biosciences (U.K.), HEMARINA (France), Hemoglobin Oxygen Therapeutics LLC (U.S.), KaloCyte Inc. (U.S.), SpheriTech Ltd. (U.K.), Centrum Medyczne VisusMed (Poland), European Medicines Agency (Netherlands), OPK Biotech Inc. (U.S.), NuvOx Pharma (U.S.), Prolong Pharmaceuticals, LLC (U.S.), Boston Pharmaceuticals (U.S.), OXYVITA Inc (U.S.), NanoBlood LLC (U.S.) |
|
Market Opportunities |
|
Market Definition
Oxygen therapeutics or haemoglobin-based oxygen carriers are other terms for artificial blood substitutes. It is used to simulate the function of biological blood and to provide an alternative to blood transfusion. Artificial blood is used to replace transfusions of banked red blood cells and is designed to overcome limitations such as a lack of blood donor, high risk of contamination, and the need for cross matching. Allogenic blood transfusions carry a number of risks, including the transmission of infectious disease, transfusion reactions, transfusion-related acute lung injury, delayed postoperative wound healing, immunomodulation, and the risk of cancer recurrence. It holds the promise of novel, life-saving medical treatments.
Global Artificial Blood Substitutes Market Dynamics
Drivers
- Rising usage of artificial blood substitutes
Animal blood, human blood, microorganisms, recombinant Hb, stem cells, and other sources are used to create artificial blood. Artificial blood has several advantages over human blood because it belongs to a universal blood group and can be administered to patients regardless of blood type. Artificial blood substitutes also do not cause any immunological reactions. Furthermore, artificial blood substitute eliminates the risk of infectious diseases or contamination during transfusion and has a longer shelf life than human blood, as it can be stored for 3 years at room temperature or more, whereas human blood has a 42-day shelf life. Artificial blood can be used in emergency situations and is easily stored. It is also an excellent option for the patients who doesn’t accept blood from donors due to their religious beliefs. These all are the certain factors which propel the growth of the market.
- Rising awareness of the benefits of artificial blood
Rising awareness of the benefits of artificial blood and rising demand for artificial blood, combined with an insufficient number of blood donors is bolstering the market growth. When blood substitutes are manufactured, bacteria and viruses can be destroyed. This reduces the risk of infectious diseases in blood transfusions, which is a major problem in many parts of Sub-Saharan Africa. An increase in research and development on artificial blood is boosting the global artificial blood substitutes market.
Opportunity
- Growing number of surgical procedures
A growing number of surgical procedures necessitate the use of artificial blood substitutes in place of donated human blood plasma or red cells. Increased funding for research on artificial blood substitutes by government and private organizations, which is likely to result in innovations and new product launches.
Restraints/Challenges
- High cost of artificial blood substitutes
High cost of artificial blood substitutes and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. For instance, most hemoglobin-based products only last 20-30 hours in the body. In comparison, whole blood transfusions last 34 days. Furthermore, these blood substitutes do not mimic the ability of blood to fight diseases and clot.
This artificial blood substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial blood substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In November 2020, Hemarina published a scientific report on the anti-inflammatory and antibacterial properties of M 101, an oxygen transporter for the treatment of periodontitis. This study validated the quality of M 101 molecule, which is derived from marine lugworm haemoglobin
- In June 2020, KaloCyte, Inc. received a USD 300,000 grant from the University System of Maryland (USM) Momentum Fund to develop ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has enabled the company to accelerate the development of the ErythroMer
- In May 2020, KaloCyte, Inc. was awarded a USD 373,000 Small Business Innovation Research (SBIR) Phase I grant by the National Institutes of Health (NIH). This grant assisted the company in advancing the KaloCyte product to preclinical safety and efficacy testing in preparation for market launch
Global Artificial Blood Substitutes Market Scope
The artificial blood substitutes market is segmented on the basis of product type, source, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Perflurocarbon (PFCs)
- Hemoglobin-Based Oxygen Carries (HBOCs)
Source
- Human Blood
- Animal Blood
- Microorganism Based Recombinant HB
- Synthetic Polymers and Stem Cells
Application
- Cardiovascular Diseases
- Malignant Neoplasma
- Injuries
- Neonatal Conditions
- Organ Transplant and Maternal Condition
End User
- Hospital and Clinics
- Blood Banks
- Others
Global Artificial Blood Substitutes Market Regional Analysis/Insights
The artificial blood substitutes market is analyzed and market size insights and trends are provided by country, product type, source, application and end user as referenced above.
The countries covered in the artificial blood substitutes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and rest of South America as part of South America.
North America is expected to dominate the artificial blood substitutes market owing to factors such as a rise in cases of road accidents, increasing prevalence of chronic diseases, and an increase in surgeries due to medical conditions.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to factors such as a rise in diabetes cases coupled with an increase in surgeries related to eye operations resulting from blindness caused by diabetes retinopathy which are major applications for HBOCs used across this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Artificial Blood Substitutes Market Share Analysis
The artificial blood substitutes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to artificial blood substitutes market.
Some of the major players operating in the artificial blood substitutes market are:
- Aurum Biosciences (U.K.)
- HEMARINA (France)
- Hemoglobin Oxygen Therapeutics LLC (U.S.)
- KaloCyte Inc. (U.S.)
- SpheriTech Ltd. (U.K.)
- Centrum Medyczne VisusMed (Poland)
- European Medicines Agency (Netherlands)
- OPK Biotech Inc. (U.S.)
- NuvOx Pharma (U.S.)
- Prolong Pharmaceuticals, LLC (U.S.)
- Boston Pharmaceuticals (U.S.)
- OXYVITA Inc (U.S.)
- NanoBlood LLC (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
- LIMITATIONS
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- Currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- primary interviews with key opinion leaders
- MULTIVARIATE MODELLING
- PRODUCT TYPE LIFELINE CURVE
- DBMR MARKET POSITION GRID
- market APPLICATION coverage grid
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- PATENT ANALYSIS OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
- DBMR ANALYSIS
- COUNTRY-LEVEL ANALYSIS
- YEARWISE ANALYSIS
- GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS
- Market Overview
- drivers
- IncreasE IN demand for blood transfusion
- Increased funding for product development
- rise in blood-related disorders and trauma cases
- limited availability of fresh blood and small storage periods of fresh blood
- Restraints
- stringent regulatory approval process
- high-cost production of artificial blood substitute
- unawareness about the artificial blood substitutes
- OPPORTUNITIES
- increase in awareness regarding the advantages of artificial blood over human blood
- risE IN demand for blood substituteS and insufficient number of blood donors
- RISE IN number of research & developments on artificial blood
- ample amount of sources for production of artificial blood substitute
- Challenges
- instability of artificial blood product
- extended clinical trails
- side effects of artificial blood substitutes
- IMPACT OF COVID-19 ON THE GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
- Aftermath of COVID-19
- Impact on Supply and Demand
- The increasing demand for blood transfusion is leading the artificial blood substitutes market.
- Conclusion
- Global Artificial blood substitutes market, by Product Type
- overview
- Hemoglobin-Based Oxygen Carries (HBOCS)
- oxyglobin
- hemopure
- Perfluorocarbon (PFCS)
- perftoran
- others
- Global Artificial blood substitutes market, by Source
- overview
- animal blood
- Human Blood
- Microorganism Based Recombinant Hb
- Stem Cells
- Synthetic Polymers
- Global Artificial blood substitutes market, by Application
- overview
- injuries
- Cardiovascular Diseases
- Organ Transplant
- Maternal Condition
- Malignant Neoplasma
- Neonatal Conditions
- Global Artificial blood substitutes market, by End user
- overview
- hospital and clinics
- blood banks
- others
- Global Artificial blood SUBSTITUTEs MARKET, by Region
- Overview
- NORTH AMERICA
- U.S.
- MEXICO
- Middle East & Africa
- South Africa
- Rest Of Middle East & Africa
- EUROPE
- FRANCE
- RUSSIA
- NETHERLAND
- U.K.
- REST OF EUROPE
- asia-pacific
- China
- Rest Of asia-pacific
- global artificial blood substitutes market: COMPANY landscape
- company share analysis: Global
- global artificial blood substitutes market: company share 2020 (%)
- company share analysis: North America
- North America artificial blood substitutes market: company share 2020 (%)
- company share analysis: Europe
- Europe artificial blood substitutes market: company share 2020 (%)
- swot
- company profile
- kalocyte, inc.
- COMPANY SNAPSHOT
- Company sahre Analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENTS
- hemarina
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENTS
- hemoglobin oxygen therapeutics llc
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENTS
- llc “visusmed”
- COMPANY SNAPSHOT
- company share analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- European Medicines Agency
- COMPANY SNAPSHOT
- Revenue Analysis
- company share analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- aurum biosciences
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENTS
- boston therapeutics, inc.
- COMPANY SNAPSHOT
- Revenue Analysis
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- nanoblood llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- nuvox pharma
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENTS
- opk biotech llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- oxyvita inc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- prolong pharmaceuticals, llc
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIo
- RECENT DEVELOPMENT
- questionnaire
- related reports
List of Table
TABLE 1 global Artificial blood substitutes Market, Product Type, 2019-2028 (USD Thousand)
TABLE 2 global Hemoglobin-Based Oxygen Carries (HBOCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 3 global HEMOGLOBIN-based oxygen carriers (HBOCs) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)
TABLE 4 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 5 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)
TABLE 6 global Artificial blood substitutes Market, by Source, 2019-2028 (USD Thousand)
TABLE 7 global animal blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 8 global human blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 9 global microorganism based recombinant hb in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 10 global stem cells in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 11 global synthetic polymers in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 12 global Artificial blood substitutes Market, by Application, 2019-2028 (USD Thousand)
TABLE 13 global injuries in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 14 global cardiovascular diseases in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 15 global organ transplant in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 16 global maternal condition in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 17 global malignant neoplasma in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 18 global neonatal conditions in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 19 global Artificial blood substitutes Market, by End user, 2019-2028 (USD Thousand)
TABLE 20 global hospitals and clinics in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 21 global blood banks in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 22 global others in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)
TABLE 23 GLOBAL Artificial blood substitutes MARKET, BY REGION, 2021-2028 (USD THOUSAND)
TABLE 24 North AMERICA Artificial blood substitutes Market, By country, 2019-2028 (USD Thousand)
TABLE 25 NORTH AMERICA Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)
TABLE 26 North America Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 27 North America Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 28 North America Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)
TABLE 29 North America Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)
TABLE 30 North America Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)
TABLE 31 U.S. Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)
TABLE 32 U.S. Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 33 U.S. Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 34 U.S. Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)
TABLE 35 U.S. Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)
TABLE 36 U.S. Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)
TABLE 37 MEXICO Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)
TABLE 38 MEXICO Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 39 MEXICO Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 40 MEXICO Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)
TABLE 41 MEXICO Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)
TABLE 42 MEXICO Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)
TABLE 43 Middle East & Africa artificial blood substitutes market, By COUNTRY, 2019-2028 (USD Thousand)
TABLE 44 Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 45 Middle East & Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 46 Middle East & Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 47 Middle East & Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)
TABLE 48 Middle East & Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)
TABLE 49 Middle East & Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)
TABLE 50 South Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 51 South Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 52 South Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 53 South Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)
TABLE 54 South Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)
TABLE 55 South Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)
TABLE 56 rest of Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)
TABLE 57 Europe artificial blood substitute Market, By COUNTRY, 2019-2028 (USD Thousand)
TABLE 58 EUROPE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 59 Europe Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 60 Europe Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 61 Europe artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)
TABLE 62 Europe artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)
TABLE 63 Europe artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)
TABLE 64 FRANCE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 65 FRANCE Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 66 FRANCE Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 67 FRANCE artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)
TABLE 68 FRANCE artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)
TABLE 69 FRANCE artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)
TABLE 70 RUSSIA artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 71 RUSSIA Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 72 RUSSIA Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 73 RUSSIA artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)
TABLE 74 RUSSIA artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)
TABLE 75 RUSSIA artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)
TABLE 76 NETHERLAND artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 77 NETHERLAND Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 78 NETHERLAND Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 79 NETHERLAND artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)
TABLE 80 NETHERLAND artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)
TABLE 81 NETHERLAND artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)
TABLE 82 U.K. artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 83 U.K. Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 84 U.K. Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)
TABLE 85 U.K. artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)
TABLE 86 U.K. artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)
TABLE 87 U.K. artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)
TABLE 88 REST OF EUROPE ARTIFICIAL blood substitute Market, By Product type, 2019-2028 (USD Thousand)
TABLE 89 Asia-Pacific artificial blood substitute market, By COUNTRY, 2019-2028 (USD Thousand)
TABLE 90 asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 91 asia-pacific Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 92 asia-pacific perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 93 asia-pacific artificial blood substitute market, By Source, 2019-2028 (USD thousand)
TABLE 94 asia-pacific artificial blood substitute market, By application, 2019-2028 (USD thousand)
TABLE 95 asia-pacific artificial blood substitute market, By end user, 2019-2028 (USD thousand)
TABLE 96 China artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 97 China Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 98 China perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)
TABLE 99 China artificial blood substitute market, By Source, 2019-2028 (USD thousand)
TABLE 100 China artificial blood substitute market, By application, 2019-2028 (USD thousand)
TABLE 101 China artificial blood substitute market, By end user, 2019-2028 (USD thousand)
TABLE 102 rest of asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)
List of Figure
FIGURE 1 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: segmentation
FIGURE 2 global artificial blood substitutes market: data triangulation
FIGURE 3 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS
FIGURE 4 Global artificial blood substitutes market: GLOBAL vs REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: market APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION
FIGURE 11 north america is expected to DOMINATE THE global artificial blood substitutes market AND GROWing WITH THE HIGHEST share IN the forecast period of 2021 To 2028
FIGURE 12 increased DEMAND FOR BLOOD TRANSFUSION is expected to drive the global artificial blood substitutes market in THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 haemoglobin-based oxygen carriers (hbocs) SEgment is expected to account for the largest share of the GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET in 2021 & 2028
FIGURE 14 north america is the fastest growing market for artificial blood substitutes manufacturers in the forEcast period of 2021 to 2028
FIGURE 15 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY
FIGURE 16 PATENT REGISTERED YEAR (2017 - 2021)
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF GLOBAL artificial blood substituteS MARKET
FIGURE 18 global Artificial blood substitutes Market, By Product Type, 2020
FIGURE 19 global Artificial blood substitutes Market, By Source, 2020
FIGURE 20 global Artificial blood substitutes Market, By Application, 2020
FIGURE 21 global Artificial blood substitutes Market, By End user, 2020
FIGURE 22 GLOBAL Artificial blood substitutes market: SNAPSHOT (2020)
FIGURE 23 GLOBAL Artificial blood substitutes market: BY REGION (2020)
FIGURE 24 GLOBAL Artificial blood substitutes market: BY REGION (2021 & 2028)
FIGURE 25 GLOBAL Artificial blood substitutes market: BY REGION (2020 & 2028)
FIGURE 26 GLOBAL Artificial blood substitutes market: BY Product Type (2021-2028)
FIGURE 27 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: SNAPSHOT (2020)
FIGURE 28 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020)
FIGURE 29 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 30 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 31 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY product type (2021-2028)
FIGURE 32 Middle East & Africa artificial blood substitutes market: SNAPSHOT (2020)
FIGURE 33 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020)
FIGURE 34 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2021 & 2028)
FIGURE 35 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020 & 2028)
FIGURE 36 Middle East & Africa artificial blood substitutes market: BY PRODUCT TYPE (2021 & 2028)
FIGURE 37 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: SNAPSHOT (2020)
FIGURE 38 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020)
FIGURE 39 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2021 & 2028)
FIGURE 40 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020 & 2028)
FIGURE 41 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY product type (2021-2028)
FIGURE 42 Asia-Pacific artificial blood substitute market: SNAPSHOT (2020)
FIGURE 43 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020)
FIGURE 44 Asia-Pacific artificial blood substitute market: BY COUNTRY (2021 & 2028)
FIGURE 45 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020 & 2028)
FIGURE 46 Asia-Pacific artificial blood substitute market: BY product TYPE (2020 & 2028)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
